Impact of Generics on the Biotechnology Industry
Abstract/Contents
- Abstract
- Joe comments on the widely held debate in the biotechnology industry about the legality and effectiveness of generic drugs. Joe feels that as long as the follow-on biologics are effective and safe, they would be great for the industry. He states the Genentech will compete by continually innovating better drugs.
Description
| Type of resource | moving image |
|---|---|
| Extent | 1 digital video file |
| Place | Stanford (Calif.) |
| Date created | November 30, 2006 |
| Language | English |
| Digital origin | born digital |
| Sound content | sound |
| Color content | color |
Creators/Contributors
| Speaker | McCracken, Joe |
|---|
Subjects
| Subject | Entrepreneurship |
|---|---|
| Subject | Business |
| Genre | Filmed lectures |
Bibliographic information
| Location | https://purl.stanford.edu/fn594tt7052 |
|---|---|
| Location | SC1209 |
| Repository | Stanford University. Libraries. Department of Special Collections and University Archives |
Access conditions
- Use and reproduction
- The materials are open for research use and may be used freely for non-commercial purposes with an attribution. For commercial permission requests, please contact the Stanford University Archives (archivesref@stanford.edu).
- Copyright
- Copyright © 2006 The Board of Trustees of the Leland Stanford Junior University. All rights reserved.
Collection
Stanford Technology Ventures Program, Entrepreneurial Thought Leaders Seminar, videorecordings
View other items in this collection in SearchWorksAlso listed in
Loading usage metrics...